Furthermore, fatty acid synthase (FAS), the key de novo lipogenesis enzyme, has increased activity in the setting of diabetes and was proven to contribute to atheroprogression in carotid arteries of patients by changing lipid species levels [35]. The gene discussed is FASN; the disease is diabetes mellitus.